Le Lézard
Classified in: Science and technology, Business
Subject: PDT

Crosschq Launches Unique Platform to Source Talent with Candidate Referral Network "Crosschq Recruit"


SAN FRANCISCO, Jan. 21, 2022 /PRNewswire/ -- Crosschq, pioneers of the Talent Intelligence Cloudtm powering a revolution in data-driven hiring and people analytics, today announced the launch of Crosschq Recruit, the world's first recruiting platform built specifically to help companies source qualified talent directly from the professional networks of job applicants.

Crosschq's Recruit allows talent leaders to effortlessly build talent pools of highly qualified candidates who are open to new career opportunities. This pool is built from individuals who served as a Crosschq 360 reference. When acting as Crosschq 360 reference, that person is invited to "opt-in" and be considered for new job opportunities across the entire Crosschq customer base. Profiles of candidates who "Opt-in" are enriched and matched through the Crosschq Talent Intelligence Cloudtm and are directly delivered to the inboxes of recruiters. 

Key features of Crosschq Recruit include:

"As we all know, there is currently a massive war for qualified talent," said Pete Goettner, Co-Founder & Chief Product Officer for Crosschq. "We listened closely to our customers and built Crosschq Recruit to make it easy for recruiters to source and hire from this great pool of qualified professionals who are actively looking for a new job."

For more information on Crosschq or to request to demo, visit https://www.crosschq.com/demo-request?utm_medium=referral&utm_source=pressrelease&utm_campaign=pressrelease-2022-jan-recruit

About Crosschq
Crosschq is powering a revolution in data-driven hiring and people analytics to help companies better recruit and retain talent. Crosschq's Talent Intelligence Cloudtm provides solutions across the new hire lifecycle to help enhance sourcing, screening, and onboarding new hires while providing a single source of truth for customers to accurately measure Quality of Hire. The company's AI-driven cloud-based SaaS solutions were built with a talent-first approach prioritizing trust and transparency, minimizing bias, and protecting privacy. Leading innovative companies like Snowflake, Hubspot, Glassdoor, Upwork and Dish Networks trust Crosschq to help build diverse, winning teams. Founded in 2018, Crosschq is backed by Tiger Global Management, GGV Capital, Bessemer Venture Partners, SAP.iO, Intersect Capital, Okta Ventures, Slack Fund, and Rocketship.vc. To learn more, visit crosschq.com.

Media Contact:
Elena Arney
[email protected]
415-361-0001

SOURCE Crosschq


These press releases may also interest you

at 06:50
Cable One, Inc. (the "Company" or "Cable One") today announced that its Board of Directors has authorized a stock repurchase program of up to $450 million of Cable One's common stock. The size and timing of any purchases will depend on a number of...

at 06:50
Pfizer Inc. and BioNTech SE today announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age. Following...

at 06:50
Spire Global, Inc. ("Spire" or "the Company"), a leading global provider of space-based data, analytics and space services, today announced it was awarded a subcontract agreement with TCOM, L.P. (TCOM), the global leader in elevated intelligence,...

at 06:37
The BSV Global Blockchain Convention welcomes the public, businesses, and the industry for the first time ever in Dubai. Come to the Grand Hyatt in Dubai between 24 May and 26 May, 2022 and be part of the conversation. The convention will play host...

at 06:36
Silverbullet, today announces the successful year-one results it has delivered for the leading pub, cider and beer company, Heineken Brazil. Silverbullet has supported the brand in reaching millions of consumers through a bespoke data strategy...

at 06:35
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the US Food and Drug Administration (FDA) has accepted and filed the Biologics License Application (BLA) for...



News published on 21 january 2022 at 08:34 and distributed by: